Is PureTech health a buy or sell?

PureTech Health's analyst rating consensus is a Moderate Buy . This is based on the ratings of 1 Wall Streets Analysts.

What is the forecast for PureTech health?

Share price forecast The 2 analysts offering 12 month price targets for Puretech Health PLC have a median target of 495.98, with a high estimate of 622.33 and a low estimate of 368.85 . The median estimate represents a 111.96% increase from the last price of 234.00.

What is the tender offer for PureTech health?

PureTech Health, a clinical-stage biotherapeutics company focused on developing treatments for devastating diseases, has successfully passed a Special Resolution during its General Meeting, approving a tender offer to purchase around 33.5 million of its ordinary shares at 250 pence each .

Who are the competitors of Puretech Health?

Puretech Health's competitors and similar companies include Trans Genic, Cogstate, Advanced Enzymes and Quadram Institute .

Is Comp a good stock to buy?

Compass stock has received a consensus rating of buy . The average rating score is and is based on 16 buy ratings, 13 hold ratings, and 1 sell ratings.

Should I accept a tender offer?

The offer may allow you to make a nice profit, although it's important to consider the potential capital gains taxes. A tender offer may not be worth accepting, though, if you're a buy-and-hold investor who believes the stock's price can soar in the long term .

Is self tender offer better than repurchase?

When companies announce an open market buyback, they generally impose a price ceiling up to which they will repurchase the share. However, unlike a tender offer, it is not necessary for them to pay a premium as they can repurchase the shares even at the current market price .

What is a tender offer for shares?

Tender offers are typically made publicly and invite shareholders to sell their shares for a specified price and within a particular window of time . The price offered is usually at a premium to the market price and is often contingent upon a minimum or a maximum number of shares sold.

Is HCA a good stock to buy?

HCA Healthcare has a consensus rating of Strong Buy which is based on 14 buy ratings, 2 hold ratings and 0 sell ratings. The average price target for HCA Healthcare is $358.13.

Is LXRX a good stock to buy?

Broker Rating. Lexicon Pharmaceuticals currently has an average brokerage recommendation (ABR) of 1.80 on a scale of 1 to 5 ( Strong Buy to Strong Sell ), calculated based on the actual recommendations (Buy, Hold, Sell etc.)

Will GPV stock go up?

The average price target for GreenPower Motor is C$5.51. This is based on 2 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is C$6.88 ,the lowest forecast is C$4.13. The average price target represents 250.96% Increase from the current price of C$1.57 .

Will VHC stock go up?

According to our current VHC stock forecast, the value of VirnetX Holding shares will rise by 14.38% and reach $ 4.75 per share by June 5, 2024. Per our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear).

Puretech Health (PRTC) Share Price (2024)

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Puretech Health Plc	LSE:PRTC	London	Ordinary Share	GB00BY2Z0H74	ORD 1P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	1.00	0.45%	225.00	373,014	16:35:22

Bid Price		Offer Price	High Price	Low Price	Open Price
223.50		224.50	230.00	222.00	230.00

Industry Sector	Turnover	Profit	EPS - Basic	PE Ratio	Market Cap
Home Health Care Services	USD23.75M	USD-50.35M	USD-0.1839	-12.21	614.83M

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
16:35:22	UT	135,400	225.00	GBX

Related Shares
Astrazeneca (AZN), Gsk (GSK), N4 Pharma (N4P), Fusion Antibodies (FAB)

Puretech Health (PRTC) Latest News

Puretech Health News

Date	Time	Source	Headline
07/6/2024	17:30	UK RNS	PureTech Health PLC Holding(s) in Company
06/6/2024	17:34	UK RNS	PureTech Health PLC Result of Meeting
04/6/2024	07:00	UK RNS	PureTech Health PLC Additional Disclosure Re: Tender Offer
03/6/2024	07:00	UK RNS	PureTech Health PLC Total Voting Rights
29/5/2024	21:30	ALNC	IN BRIEF: PureTech's Ankili to be acquired by Virtual Therapeutics
29/5/2024	13:04	UK RNS	PureTech Health PLC PRTC's Akili Enters Into Merger Agreement
23/5/2024	12:00	UK RNS	PureTech Health PLC PRTC to Present at Jefferies Healthcare Conference
21/5/2024	14:07	ALNC	PureTech-founded Vedanta begins trials for VE303 colonic bacteria drug
21/5/2024	12:05	UK RNS	PureTech Health PLC PRTC's Vedanta Begins Phase 3 of VE303 in C. diff
20/5/2024	09:03	ALNC	IN BRIEF: PureTech Health launches USD100 million buyback programme

Puretech Health (PRTC) Discussions and Chat

Puretech Health Forums and Chat

Date	Time	Title	Posts
11/6/2024	10:27	PureTech Health - innovative healthcare	2,037
22/7/2018	21:35	PureTech Health (PRTC) One to Watch Monday	-

Add a New Thread

Puretech Health (PRTC) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
15:35:22	225.00	135,400	304,650.00	UT
15:29:57	224.50	5	11.23	AT
15:24:44	224.00	31	69.44	AT
15:24:02	224.00	20	44.80	AT
15:23:26	223.50	77	172.10	AT

View all Puretech Health trades in real-time

Puretech Health (PRTC) Top Chat Posts

Top Posts
Posted at 11/6/2024 09:20 by Puretech Health Daily Update Puretech Health Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 224p. Puretech Health currently has 273,866,153 shares in issue. The market capitalisation of Puretech Health is £614,829,513. Puretech Health has a price to earnings ratio (PE ratio) of -12.21. This morning PRTC shares opened at 230p Read Full Thread Reply
Posted at 10/6/2024 17:33 by takeiteasy Perhaps it is far more simple atm and the main beneficiary of this improved interest in these shares has been for Invesco to sell down against. Can we imagine that they might pitch to sell as many of their holdings as possible at the 2.50 price being set - would reduce the chance of a dividend for those of us holding on and not selling? Read Full Thread Reply
Posted at 05/6/2024 06:55 by jaws6 IC got new short list and PRTC is not in there, not sure who is right, FT or IC. lets wait for news soon. Read Full Thread Reply
Posted at 04/6/2024 14:45 by rambutan2 FT has piece today on bad time for hedge funds shorting UK mkt. Lists top 10 most shorted stocks and I spot PRTC in the list with 8.5% shorted. Read Full Thread Reply
Posted at 03/6/2024 12:26 by return_of_the_apeman I am struggling to see the point in tendering any of my shares now. Mathematically removing 12% of shares in circulation should mean I am better off not tendering and if there is little take up then that news and a large special divi could see the share price rise substancially into x-div. Read Full Thread Reply
Posted at 22/3/2024 15:03 by linton5 Share price is exactly where it was 1year ago I take it not much has happened 🤔 Read Full Thread Reply
Posted at 21/3/2024 10:33 by wassapper So please help me here. The tender offer will be at 250p per share (if it proceeds)? Current share price is 222p So if I buy more now (to add to my goodly amount), sometime in April/May, I'll be offered 250p a share for some of my shares by the company? Do I make an "instant" 28p per share or just for a proportion? If so why aren't more share being bought? What happends to the share price after the tender offer (all things being equal)? Does it drop like a typical ex-divi action? First time tender for me so quite confused. I am sure many of these questions will be asked again! Thanks! Read Full Thread Reply
Posted at 19/3/2024 12:35 by fozzie The stock market is crazy. You often get companies doing a small placing at a 20% discount and the share price drops to the placing price almost straightaway even though it might only be 5% of share capital. Read Full Thread Reply
Posted at 19/3/2024 12:30 by return_of_the_apeman As the share price gets closer to £2.50, more will be inclined not to tender, which may mean a special divi as indicated Looking forward to publication of results at the end of April Read Full Thread Reply
Posted at 16/3/2024 12:58 by colinblackbourn Karuna $14bn closing frees up cash from the big holders.Fidelity will have made several billion dollars for example.100pc owned Seaport and Gallop will be looking for investors ahead of eventual IPO..Remember Seaport is 'Karuna on Steroids'.both ultimate valuations in for free.I wonder what the share price will be by the final results at the end of April. Read Full Thread Reply
Posted at 23/2/2024 14:06 by takeiteasy I know folks are all loading up here - but given the note at the top of the page notes value in the share at 1.42 in 2016 - what on earth has happened in the interim etc etc..given what must have been a very tough 8 years to 2024 what is a realistic target price now that some might take profits at. We have such a crazy range of numbers up to about 10 quid which almost seems mad to suggest in the light of dreadful share price performance over such a long 8 year period.. Read Full Thread Reply

Puretech Health share price data is direct from the London Stock Exchange

Loading Follow Feed...

See More on the Follow Feed

{{companyName}} ({{ticker}}) {{{eventMessage}}}